Navigation Links
FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
Date:9/12/2007

Committees also recommend further changes to US Label for Trasylol(R) and

additional safety studies

LEVERKUSEN, Germany and WEST HAVEN, Conn., Sept. 12 /PRNewswire/ -- Today, the Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to the U.S. Food and Drug Administration (FDA) held a meeting to discuss the risk /benefit profile of Trasylol(R) (aprotinin injection), a Bayer drug used in coronary artery bypass graft (CABG) surgery. At the close of the meeting, based on the Trasylol(R) data in Bayer's controlled clinical studies and after considering data from observational studies and public testimony presented at the meeting, the Committees recommended that U.S. marketing authorization for Trasylol(R) should be continued.

The Committees also recommended that Bayer amend the U.S. product label for Trasylol(R) to provide additional prescribing guidance to physicians and also recommended that Bayer conduct additional clinical studies, including randomized controlled trials, to further assess the risk and benefit of Trasylol(R).

Bayer was pleased to participate in today's session because it provided a proper forum in which to discuss the complex scientific issues surrounding the risk/benefit profile of Trasylol(R) in detail. Trasylol(R) is the only drug currently approved by the FDA for prophylactic use to reduce perioperative blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery who are at an increased risk for blood loss and blood transfusion.

Patient safety is Bayer's first and foremost concern. In line with the discussions and guidance received from the Committees today, the company will work with FDA on appropriate U.S. label revisions providing additional prescribing guidance to physicians.

The Committees also recommended that Bayer undertake additional clin
'/>"/>

SOURCE Bayer
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
2. FDA Announces Change of Location Notice for Upcoming Advisory Committee Meeting
3. Media Advisory: ACC Updated Schedule
4. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
5. Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke
6. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)...  Today, the National Patient Advocate Foundation acknowledges that ... Representatives recently approved a bill that would prohibit insurers ... out-of-pocket fees for newer, more expensive oral anti-cancer drugs ... severe side-effects. However, the bill was amended to include ... to be a barrier to patients with cancer and ...
(Date:5/16/2013)... 16, 2013  Amgen (NASDAQ: AMGN ) will ... May 21, 2013, at the Sheraton New York Times Square ... 10:00 a.m. Eastern Daylight Time. Joseph P. Miletich ... Development at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/16/2013)... 16, 2013  ULURU Inc. (OTCQB: ULUR) today announced its ... and provided a review of its operating activities. ... the previously communicated outlook for 2013: , Launching Altrazeal ... network of distribution partners to cover all major markets excluding ... ® to be marketed in approximately 50 markets by ...
Breaking Medicine Technology:National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3ULURU Inc. Reports First Quarter 2013 Financial Results 2ULURU Inc. Reports First Quarter 2013 Financial Results 3ULURU Inc. Reports First Quarter 2013 Financial Results 4ULURU Inc. Reports First Quarter 2013 Financial Results 5
... Calif. , June 4 Derycz Scientific, Inc. ... fresh way of facilitating the flow of information from content ... Reprints Desk, an award-winning provider of information services and content ... events: Digital Pharma West , being held in ...
... VIEW, Calif. , June 3 Alexza Pharmaceuticals, Inc. (Nasdaq: ... will present during the Jefferies 2010 Global Life Sciences Conference.  The Alexza ... pm ET .  The presentation will be webcast from the Grand Hyatt Hotel ... , , ...
Cached Medicine Technology:Derycz Scientific to Exhibit at Digital Pharma West and Digital Pharma East 2Derycz Scientific to Exhibit at Digital Pharma West and Digital Pharma East 3Derycz Scientific to Exhibit at Digital Pharma West and Digital Pharma East 4Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference 2Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference 3
(Date:5/18/2013)... Dr. Robert Tracey, an area leader in dental laser ... of the root causes of sleep apnea to provide and ... Sleep Month, Dr. Tracey points out estimates revealing that 40 ... sleep apnea is one of the most common of all. ... breathing at different times while sleeping. When this happens, the ...
(Date:5/18/2013)... John Ravera, D.D.S., a Newport Beach cosmetic dentist ... to his dental team, Courtney Marino. , Marino is a ... 10 years. She received her degree from West Coast University, ... of Sigma Pi Alpha, a national honor society for individuals ... of all ages, helping them understand the importance of preventing ...
(Date:5/18/2013)... According to the the Stevens Johnson Syndrome Foundation, ... is a severe allergic reaction usually to medicine (i). ... can quickly advance causing blistering and large areas of dead ... SJS can develop at any time and seriously affect both ... Manute Bol, passed away after he received kidney medicine which ...
(Date:5/18/2013)... The product liability attorneys at Wright & Schulte ... consumers nationwide who have sustained serious tendon injuries allegedly caused ... are all part of MDL 2308 and were all filed ... be heard in the U.S. District Court of the Western ... LLC specializes in defending the rights of those who have ...
(Date:5/17/2013)... 2013 Daily Gossip announced on Monday that ... of the Program Yourself Thin regime, Jim Katsoulis. ... website by the end of the month in order to ... reeducate themselves and lead a healthy lifestyle, free of food ... package is available for only $97 and it comes ...
Breaking Medicine News(10 mins):Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 3Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 4Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2
... men are more at risk of diseases caused by blood ... of diseases caused by the inappropriate formation of a blood ... and stroke, but the reasons for this are not completely ... California, San Francisco, have used a mouse model of thrombosis ...
... review of 11 anti-seizure drugs that showed double the ... Anti-seizure drugs can cause increased suicidal tendencies in patients, ... 20-member panel of experts voted unanimously to back the ... Food and Drug Administration, the Associated Press ...
... are just a few of the extra costs that ... a new study that will be published in current ... social work at Washington University in St. Louis, found ... children,s special needs have different out-of-pocket health expenditures depending ...
... Today, PRINCETON, N.J., July 10 ... alerts and travel security,information from renowned intelligence ... http://www.securassist.com . The redesigned site, launched today, ... for preventing and,handling travel security emergencies., ...
... reported preliminary total retail drug,store sales for the 5-week, 9-week and 22-week periods ended July 3, 2008., , ... Periods ended July 3, 2008, ... Quarter Year ... to Date to Date (Dollars in millions) ...
... from UCLA and the Veterans Affairs Greater Los Angeles ... wearable artificial kidney, or AWAK, that avoids the complications ... , The design for the peritoneal-based artificial kidney ... loss and other dialysis-related problems is summarized in ...
Cached Medicine News:Health News:JCI online early table of contents: July 10, 2008 2Health News:JCI online early table of contents: July 10, 2008 3Health News:JCI online early table of contents: July 10, 2008 4Health News:JCI online early table of contents: July 10, 2008 5Health News:JCI online early table of contents: July 10, 2008 6Health News:JCI online early table of contents: July 10, 2008 7Health News:JCI online early table of contents: July 10, 2008 8Health News:Epilepsy Drugs Can Cause Suicidal Tendencies, FDA Panel Finds 2Health News:Epilepsy Drugs Can Cause Suicidal Tendencies, FDA Panel Finds 3Health News:Cost of raising a child with special needs: Where does your state rank? 2Health News:Assist America's New SecurAssist Website Features Top Travel Security Information Powered by iJET 2Health News:Longs Reports Preliminary June Retail Drug Store Sales 2Health News:Researchers design model for automated, wearable artificial kidney 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: